Tzu-i Chao
No. 7, Chung Shan South Road, 100
TPQ, Taiwan
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: August 25, 2022
TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1.
Journal: Cancer letters
Published: February 28, 2020
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 09, 2018
Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112 (October) (2017) 81-89].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2018
Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112, (October) (2017) 81-89].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 24, 2018
Antagonizing SET Augments the Effects of Radiation Therapy in Hepatocellular Carcinoma through Reactivation of PP2A-Mediated Akt Downregulation.
Journal: The Journal of pharmacology and experimental therapeutics
Published: March 13, 2018
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 03, 2017
Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 04, 2017
Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
Journal: Biochemical pharmacology
Published: January 26, 2017
Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner.
Journal: Molecular oncology
Published: December 01, 2016
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 09, 2016
Last Updated: 09/26/2026